Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The Thread Formerly Known as No Rest For The Wicked -- Ignore unavailable to you. Want to Upgrade?

To: Tim Luke who wrote (57244)	9/7/1999 10:00:00 AM
From: QuietWon	Read Replies (1) \| Respond to of 90042

in cs, not in pios (got with what i've researched -- layer 3,4,5+ network processors; ATM /sonet layer tech), etc - not as familiar with PIOS sector

To: Tim Luke who wrote (57244)	9/7/1999 10:02:00 AM
From: QuietWon	Read Replies (1) \| Respond to of 90042

Tim, sorry to pound the tbl on ORCL (& now APNT), but i-net software technicals reversed a few weeks ago on the Point & Figure

To: Tim Luke who wrote (57244)	9/7/1999 10:09:00 AM
From: QuietWon	Respond to of 90042

DRMD - Cenestin approved - should see sales. All pharma co's had to look at and change their accounting in 1997 & 1998 b/c of a regulatory change - 1999 results stay the same -- mis unnderstood by the market, imo -- overdone